Verapamil: full spectrum calcium channel blocking agent: an overview.
Oral verapamil approved for use in all forms of angina, with its additional heart rate-controlling properties has undergone extensive clinical investigation and use since its initial development and has been demonstrated to be safe, well-tolerated and effective over a broad range of cardiovascular disorders. Further potential therapeutic indications for verapamil use remain to be assessed. Additional research with this exciting drug is ongoing.
D002118:Calcium / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D007700:Kinetics; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D014700:Verapamil / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*
D007473:Ion Channels; D014700:Verapamil; D002118:Calcium